☰

Steven C. Eck, Ph.D. - Publications

Affiliations: 
2000 University of Pennsylvania, Philadelphia, PA, United States 
Area:
Immunology
Tree Info Grants Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Bendell J, LoRusso P, Overman M, Noonan AM, Kim DW, Strickler JH, Kim SW, Clarke S, George TJ, Grimison PS, Barve M, Amin M, Desai J, Wise-Draper T, Eck S, et al. First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors. Cancer Immunology, Immunotherapy : Cii. PMID 37016126 DOI: 10.1007/s00262-023-03430-6  0.37
2019 Karnell JL, Albulescu M, Drabic S, Wang L, Moate R, Baca M, Oganesyan V, Gunsior M, Thisted T, Yan L, Li J, Xiong X, Eck SC, de Los Reyes M, Yusuf I, et al. A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity. Science Translational Medicine. 11. PMID 31019027 DOI: 10.1126/Scitranslmed.Aar6584  0.523
2018 Oberst MD, Auge C, Morris C, Kentner S, Mulgrew K, McGlinchey K, Hair J, Hanabuchi S, Du Q, Damschroder M, Feng H, Eck S, Buss N, de Haan L, Pierce AJ, et al. Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein. Molecular Cancer Therapeutics. PMID 29545330 DOI: 10.1158/1535-7163.MCT-17-0200  0.506
2009 Cao T, Soto A, Zhou W, Wang W, Eck S, Walker M, Harriman G, Li L. Ex vivo expanded human CD4+CD25+Foxp3+ regulatory T cells prevent lethal xenogenic graft versus host disease (GVHD). Cellular Immunology. 258: 65-71. PMID 19410243 DOI: 10.1016/J.Cellimm.2009.03.013  0.451
2006 Eck SC, Zhu P, Pepper M, Bensinger SJ, Freedman BD, Laufer TM. Developmental alterations in thymocyte sensitivity are actively regulated by MHC class II expression in the thymic medulla. Journal of Immunology (Baltimore, Md. : 1950). 176: 2229-37. PMID 16455979 DOI: 10.4049/Jimmunol.176.4.2229  0.582
2001 Eck SC, Turka LA. Adoptive transfer enables tumor rejection targeted against a self-antigen without the induction of autoimmunity. Cancer Research. 61: 3077-83. PMID 11306490  0.494
1999 Eck SC, Turka LA. Generation of protective immunity against an immunogenic carcinoma requires CD40/CD40L and B7/CD28 interactions but not CD4(+) T cells. Cancer Immunology, Immunotherapy : Cii. 48: 336-41. PMID 10473809 DOI: 10.1007/S002620050583  0.646
1999 Zhang Q, Lee B, Korecka M, Li G, Weyland C, Eck S, Gessain A, Arima N, Lessin SR, Shaw LM, Luger S, Kamoun M, Wasik MA. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I (+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia Leukemia Research. 23: 373-384. PMID 10229324 DOI: 10.1016/S0145-2126(98)00173-8  0.304
1997 Eck SC, Chang D, Wells AD, Turka LA. Differential down-regulation of CD28 by B7-1 and B7-2 engagement. Transplantation. 64: 1497-9. PMID 9392322 DOI: 10.1097/00007890-199711270-00025  0.637
Show low-probability matches.